rethinkPeptides Search
Menu
Study breakdown

Opioid Peptides Rise During Blood Pressure Spikes in Hypertensive Patients

Clinical TrialModerate evidence
The takeaway

During acute blood pressure increases in hypertensive patients, beta-endorphin, met-enkephalin, and dynorphin B levels all changed significantly, alongside natriuretic peptide and endothelin-1 alterations.

3 opioid peptides altered in BP spikes

Beta-endorphin, met-enkephalin, and dynorphin B all showed significant changes during acute hypertensive episodes

What the researchers found

Beta-endorphin, met-enkephalin, and dynorphin B levels changed significantly during acute blood pressure increases in hypertensive patients, alongside ANF and endothelin-1 alterations.

Why it matters

Understanding the opioid system's role in hypertensive crises could lead to new treatment strategies using opioid pathway modulation for blood pressure management.

How the study worked

Clinical trial measuring plasma levels of three opioid peptides, catecholamines, ANF, and endothelin-1 in hypertensive patients before and after naloxone administration during acute BP episodes.

What this study cannot tell us

Clinical trial in selected hypertensive patients during acute episodes. Small study with limited generalizability. Naloxone has its own cardiovascular effects.

How to read the evidence

Moderate clinical evidence from a naloxone-challenge study in hypertensive patients.

When this study was published

Published in 1997, contributing to understanding of opioid involvement in cardiovascular regulation.

The bigger picture

This study placed opioid peptides alongside established cardiovascular mediators (ANF, endothelin) in the complex regulatory network of blood pressure control.

Questions still open

  • Could opioid pathway modulation help manage hypertensive crises?
  • Are baseline opioid peptide levels predictive of hypertension severity?

Common questions

Why do opioid peptides change during blood pressure spikes?
The body releases opioid peptides as part of its stress response during acute BP increases. These peptides may serve as natural vasodilators trying to bring blood pressure back down, or they may reflect the intensity of the cardiovascular stress.
What does the naloxone test reveal?
Naloxone blocks opioid receptors. By measuring blood pressure before and after naloxone, researchers can determine how much of the blood pressure response is mediated by opioid peptides.

Read the original research

Pressor effects of endogenous opioid system during acute episodes of blood pressure increases in hypertensive patients.

Hypertension (Dallas, Tex. : 1979), 29(1 Pt 1), 105-10

Citation

Fontana, F; Bernardi, P; Spampinato, S; Boschi, S; De Iasio, R; Grossi, G. (1997). Pressor effects of endogenous opioid system during acute episodes of blood pressure increases in hypertensive patients.. Hypertension (Dallas, Tex. : 1979), 29(1 Pt 1), 105-10.